Blood cell activation as an indicator of prothrombogenesis in polycythemia vera: Case control study
BACKGROUND: Polycythemia vera (PV) is a chronic myeloproliferative stem cell disease usually combined with JAK2 mutation. Active JAK2 mutation directly promote platelets and granulocytes activation and indirectly initiate endothelial activation. Such interactions can provoke endothelial injury with...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
| Series: | Iraqi Journal of Hematology |
| Subjects: | |
| Online Access: | http://www.ijhonline.org/article.asp?issn=2072-8069;year=2019;volume=8;issue=2;spage=74;epage=80;aulast=Mahmood |
| _version_ | 1811288295655604224 |
|---|---|
| author | Ibrahim A Mahmood Farqad B Hamdan Waseem F Al-Tameemi |
| author_facet | Ibrahim A Mahmood Farqad B Hamdan Waseem F Al-Tameemi |
| author_sort | Ibrahim A Mahmood |
| collection | DOAJ |
| description | BACKGROUND: Polycythemia vera (PV) is a chronic myeloproliferative stem cell disease usually combined with JAK2 mutation. Active JAK2 mutation directly promote platelets and granulocytes activation and indirectly initiate endothelial activation. Such interactions can provoke endothelial injury with subsequent release of procoagulant factors. The aim of this study was to understand of this study is to understand the pathophysiology of increased thrombosis in PV in terms of the effect of JAK2V617F gene mutation in relation to the intensity of the neutrophil CD11b and platelet CD62P.
SUBJECTS AND METHODS: A group of 53 patients was examined comprised 30 PV patients and 23 with secondary polycythemia. In parallel, 30 aged- and sex-matched, nonsmokers healthy volunteers served as a control group. Hemoglobin level, packed cell volume, white and red blood cells count, mean corpuscular volume, and platelet count were estimated for all the 83 participants. Flow cytometry for the detection of neutrophil CD11b and platelet CD62P were done for all the participants; whereas quantitative polymerase chain reaction technique for the assessment of JAK2 mutation rate was done for the 30 PV patients only.
RESULTS: We were able to detect significantly higher neutrophil CD11b and platelet CD62P expressions in PV patients. Within PV, JAK2 mutation rate was significantly higher in those with a history of thrombosis. A positive relationship was demonstrated between the JAK2 mutation rate and each of CD11b and CD62P.
CONCLUSION: There is an overexpression of neutrophil CD11b and platelets CD62P in patients with PV which can be considered as a marker of procoagulant activity in blood cells. Active JAK2 mutation directly promote platelets and granulocytes activation and indirectly initiate endothelial activation and in turn endothelium into a proadhesive and procoagulant surface. |
| first_indexed | 2024-04-13T03:34:47Z |
| format | Article |
| id | doaj.art-525a1f74857644cd9cce21e5f14a5474 |
| institution | Directory Open Access Journal |
| issn | 2072-8069 |
| language | English |
| last_indexed | 2024-04-13T03:34:47Z |
| publishDate | 2019-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Iraqi Journal of Hematology |
| spelling | doaj.art-525a1f74857644cd9cce21e5f14a54742022-12-22T03:04:22ZengWolters Kluwer Medknow PublicationsIraqi Journal of Hematology2072-80692019-01-0182748010.4103/ijh.ijh_10_19Blood cell activation as an indicator of prothrombogenesis in polycythemia vera: Case control studyIbrahim A MahmoodFarqad B HamdanWaseem F Al-TameemiBACKGROUND: Polycythemia vera (PV) is a chronic myeloproliferative stem cell disease usually combined with JAK2 mutation. Active JAK2 mutation directly promote platelets and granulocytes activation and indirectly initiate endothelial activation. Such interactions can provoke endothelial injury with subsequent release of procoagulant factors. The aim of this study was to understand of this study is to understand the pathophysiology of increased thrombosis in PV in terms of the effect of JAK2V617F gene mutation in relation to the intensity of the neutrophil CD11b and platelet CD62P. SUBJECTS AND METHODS: A group of 53 patients was examined comprised 30 PV patients and 23 with secondary polycythemia. In parallel, 30 aged- and sex-matched, nonsmokers healthy volunteers served as a control group. Hemoglobin level, packed cell volume, white and red blood cells count, mean corpuscular volume, and platelet count were estimated for all the 83 participants. Flow cytometry for the detection of neutrophil CD11b and platelet CD62P were done for all the participants; whereas quantitative polymerase chain reaction technique for the assessment of JAK2 mutation rate was done for the 30 PV patients only. RESULTS: We were able to detect significantly higher neutrophil CD11b and platelet CD62P expressions in PV patients. Within PV, JAK2 mutation rate was significantly higher in those with a history of thrombosis. A positive relationship was demonstrated between the JAK2 mutation rate and each of CD11b and CD62P. CONCLUSION: There is an overexpression of neutrophil CD11b and platelets CD62P in patients with PV which can be considered as a marker of procoagulant activity in blood cells. Active JAK2 mutation directly promote platelets and granulocytes activation and indirectly initiate endothelial activation and in turn endothelium into a proadhesive and procoagulant surface.http://www.ijhonline.org/article.asp?issn=2072-8069;year=2019;volume=8;issue=2;spage=74;epage=80;aulast=Mahmoodcd11bcd62pflow cytometryjak2polycythemia vera |
| spellingShingle | Ibrahim A Mahmood Farqad B Hamdan Waseem F Al-Tameemi Blood cell activation as an indicator of prothrombogenesis in polycythemia vera: Case control study Iraqi Journal of Hematology cd11b cd62p flow cytometry jak2 polycythemia vera |
| title | Blood cell activation as an indicator of prothrombogenesis in polycythemia vera: Case control study |
| title_full | Blood cell activation as an indicator of prothrombogenesis in polycythemia vera: Case control study |
| title_fullStr | Blood cell activation as an indicator of prothrombogenesis in polycythemia vera: Case control study |
| title_full_unstemmed | Blood cell activation as an indicator of prothrombogenesis in polycythemia vera: Case control study |
| title_short | Blood cell activation as an indicator of prothrombogenesis in polycythemia vera: Case control study |
| title_sort | blood cell activation as an indicator of prothrombogenesis in polycythemia vera case control study |
| topic | cd11b cd62p flow cytometry jak2 polycythemia vera |
| url | http://www.ijhonline.org/article.asp?issn=2072-8069;year=2019;volume=8;issue=2;spage=74;epage=80;aulast=Mahmood |
| work_keys_str_mv | AT ibrahimamahmood bloodcellactivationasanindicatorofprothrombogenesisinpolycythemiaveracasecontrolstudy AT farqadbhamdan bloodcellactivationasanindicatorofprothrombogenesisinpolycythemiaveracasecontrolstudy AT waseemfaltameemi bloodcellactivationasanindicatorofprothrombogenesisinpolycythemiaveracasecontrolstudy |